Drug details
Vemlidy Tablets (tenofovir alafenamide)
type of Hepatitis B, NRTIs
Vemlidy (tenofovir alafenamide) is a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor and is indicated for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease.
The drug is often used to treat Liver disease .
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- loss of appetite,
- dark urine,
- vomiting,
- confusion,
- stomach pain,
- little or no urination,
- mood changes,
- drowsiness,
- anxiety,
- depression,
- severe dizziness
- yellowing of the eyes or skin (jaundice),
- unusual thirst,
- unusual weakness, and
- deep or rapid breathing,
The following drugs are related to Vemlidy Tablets, either as a replacement or used together:
- Hepsera (adefovir dipivoxil)
- Alphanate (antihemophilic factor)
- Baygam (immune globulin)
- Comvax (haemophilus b conjugate and hepatitis b vaccine)
- Daklinza (daclatasvir tablets)
- Dovato (dolutegravir and lamivudine tablets)
- Egrifta SV (tesamorelin for injection)
- Emtriva (emtricitabine)
- Epivir-HBV (lamivudine tablets and oral solution)
- gamaSTAN (immune globulin (human) for injection)
- Havrix (hepatitis a vaccine, inactivated)
- Twinrix (hepatitis a inactivated & hepatitis b (recombinant) vaccine)
- Sunlenca (lenacapavir tablets and injection)
- Rebetol (ribavirin)